Provided by Tiger Fintech (Singapore) Pte. Ltd.

ESSA Pharma

1.48
-0.1000-6.33%
Post-market: 1.500.0200+1.35%19:47 EDT
Volume:311.58K
Turnover:471.96K
Market Cap:65.70M
PE:-2.11
High:1.59
Open:1.57
Low:1.43
Close:1.58
Loading ...
Sep 18, 2023

Major Issues Report

Form 8-K - Current report
Sep 18, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 07, 2023

Major Issues Report

Form 8-K - Current report
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 12, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 07, 2023

Major Issues Report

8-K - Current report
Dec 13, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 13, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals